Aug. 5 (Bloomberg) -- King Pharmaceuticals Inc.'s call- option trading was the busiest since 2004 and its shares rose to an 11-month high on speculation Pfizer Inc., the biggest U.S. drugmaker by market value, will buy the company.
Aug. 5 (Bloomberg) -- King Pharmaceuticals Inc.'s call- option trading was the busiest since 2004 and its shares rose to an 11-month high on speculation Pfizer Inc., the biggest U.S. drugmaker by market value, will buy the company.
